Headlines Covid-19 Specialties Trending Feeds Videos

Amgen’s $1.9B Five Prime deal adds to cancer drug pipeline and Asia strategy – MedCity News

posted 11 hours


MedCity News - The acquisition brings Amgen a novel Phase 3-ready drug for gastric cancers. For Five Prime Therapeutics, the deal is a lifeline following a series...